| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.PHARMTHERA.2010.11.002 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0163725810002172?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S0163725810002172?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 21111758 |
| P5875 | ResearchGate publication ID | 49639637 |
| P50 | author | Simon Kennedy | Q88194959 |
| P2093 | author name string | Marie-Ann Ewart | |
| P2860 | cites work | Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade | Q21245891 |
| Role of AMP-activated protein kinase in mechanism of metformin action | Q22241898 | ||
| AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling | Q22241925 | ||
| Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding | Q22253261 | ||
| MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm | Q24296287 | ||
| Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD | Q24305094 | ||
| Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase | Q24309462 | ||
| Identification of a novel AMP-activated protein kinase beta subunit isoform that is highly expressed in skeletal muscle | Q24313307 | ||
| The AMP-activated protein kinase--fuel gauge of the mammalian cell? | Q24315074 | ||
| Characterization and regulation of reductase kinase, a protein kinase that modulates the enzymic activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Q24561682 | ||
| CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations | Q24614590 | ||
| Intrasteric control of AMPK via the gamma1 subunit AMP allosteric regulatory site | Q24645338 | ||
| Upregulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes | Q24656627 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| The Snf1 protein kinase and its activating subunit, Snf4, interact with distinct domains of the Sip1/Sip2/Gal83 component in the kinase complex | Q27939219 | ||
| A serine/threonine kinase gene defective in Peutz-Jeghers syndrome | Q28119198 | ||
| A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle | Q28199222 | ||
| Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase | Q28215845 | ||
| AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location | Q28243750 | ||
| Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction | Q28271470 | ||
| In smooth muscle, FK506-binding protein modulates IP3 receptor-evoked Ca2+ release by mTOR and calcineurin | Q28281084 | ||
| Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase | Q28291824 | ||
| Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase | Q28296225 | ||
| Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization | Q28348247 | ||
| Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes | Q28507295 | ||
| AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase | Q42165233 | ||
| Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells | Q42476708 | ||
| Phenotypic and functional changes in regenerated porcine coronary endothelial cells : increased uptake of modified LDL and reduced production of NO. | Q42487303 | ||
| The low activity of acetyl-CoA carboxylase in basal and glucagon-stimulated hepatocytes is due to phosphorylation by the AMP-activated protein kinase and not cyclic AMP-dependent protein kinase. | Q42504598 | ||
| Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents. | Q42509038 | ||
| Comparison of vascular relaxation, lipolysis and glucose uptake by peroxisome proliferator-activated receptor-gamma activation in +db/+m and +db/+db mice | Q42515022 | ||
| Modulation by peroxynitrite of Akt- and AMP-activated kinase-dependent Ser1179 phosphorylation of endothelial nitric oxide synthase. | Q42523433 | ||
| AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633 | Q42582636 | ||
| Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues | Q42805365 | ||
| Adenosine monophosphate activated protein kinase regulates ABCG1-mediated oxysterol efflux from endothelial cells and protects against hypercholesterolemia-induced endothelial dysfunction | Q43097840 | ||
| Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion | Q43132682 | ||
| Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5. | Q43186674 | ||
| Akt kinase reducing endoplasmic reticulum Ca2+ release protects cells from Ca2+-dependent apoptotic stimuli | Q43248509 | ||
| A-769662 activates AMPK beta1-containing complexes but induces glucose uptake through a PI3-kinase-dependent pathway in mouse skeletal muscle. | Q43298108 | ||
| Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice | Q44079684 | ||
| Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells | Q44273159 | ||
| Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats | Q44303781 | ||
| Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells | Q44468960 | ||
| Cells derived from regenerated endothelium of the porcine coronary artery contain more oxidized forms of apolipoprotein-B-100 without a modification in the uptake of oxidized LDL. | Q44540704 | ||
| AICAR stimulates adiponectin and inhibits cytokines in adipose tissue | Q44807015 | ||
| Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species | Q44987425 | ||
| Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus | Q44995520 | ||
| Thrombin and histamine stimulate endothelial nitric-oxide synthase phosphorylation at Ser1177 via an AMPK mediated pathway independent of PI3K-Akt | Q45029420 | ||
| Metabolic activation of AMP kinase in vascular smooth muscle | Q45065640 | ||
| Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation. | Q46116517 | ||
| AMP-activated kinase may suppress NADPH oxidase activation in vascular tissues | Q46139590 | ||
| Statins activate AMP-activated protein kinase in vitro and in vivo | Q46230916 | ||
| Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes. | Q46236023 | ||
| Inhibition of tumor necrosis factor alpha-stimulated monocyte adhesion to human aortic endothelial cells by AMP-activated protein kinase | Q46359191 | ||
| Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase | Q46368505 | ||
| Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase | Q28567006 | ||
| The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro | Q28582647 | ||
| The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin | Q28590162 | ||
| LKB1 is the upstream kinase in the AMP-activated protein kinase cascade | Q28610414 | ||
| Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide | Q29547245 | ||
| Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain | Q29615210 | ||
| AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism | Q29617261 | ||
| 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? | Q29618095 | ||
| The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? | Q29618125 | ||
| Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction | Q29618673 | ||
| Structure and function of AMP-activated protein kinase. | Q30375195 | ||
| AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. | Q32043995 | ||
| Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro | Q33249851 | ||
| Development of novel adenosine monophosphate-activated protein kinase activators | Q33532741 | ||
| Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products | Q33595290 | ||
| Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo | Q33675689 | ||
| Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells | Q33717436 | ||
| Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase | Q33796165 | ||
| The protease inhibitor UCF-101 ameliorates streptozotocin-induced mouse cardiomyocyte contractile dysfunction in vitro: role of AMP-activated protein kinase | Q33827744 | ||
| Activation of AMP-activated protein kinase alpha1 alleviates endothelial cell apoptosis by increasing the expression of anti-apoptotic proteins Bcl-2 and survivin | Q33832521 | ||
| AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function | Q33848040 | ||
| Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo | Q33869754 | ||
| AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation | Q33874358 | ||
| Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response | Q33912715 | ||
| Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase | Q33953064 | ||
| Peroxynitrite Increases Protein Phosphatase Activity and Promotes the Interaction of Phospholamban with Protein Phosphatase 2a in the Myocardium. | Q34018767 | ||
| AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes | Q34059872 | ||
| Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway | Q34132341 | ||
| A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. | Q34196949 | ||
| AMPK beta subunit targets metabolic stress sensing to glycogen | Q34196956 | ||
| Adenosine monophosphate-activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice | Q34236808 | ||
| The structure of a domain common to archaebacteria and the homocystinuria disease protein | Q34415436 | ||
| Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. | Q34438345 | ||
| Life-long caloric restriction elicits pronounced protection of the aged myocardium: A role for AMPK | Q34440321 | ||
| AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle | Q34452979 | ||
| Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes | Q46396936 | ||
| A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). | Q46528602 | ||
| Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells | Q46665864 | ||
| Cilostazol activates AMP-activated protein kinase and restores endothelial function in diabetes | Q46680292 | ||
| Rosiglitazone stimulates nitric oxide synthesis in human aortic endothelial cells via AMP-activated protein kinase. | Q46731659 | ||
| Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action | Q46745033 | ||
| Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK. | Q46810678 | ||
| Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats. | Q46828442 | ||
| Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491. | Q46844438 | ||
| Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells. | Q46890287 | ||
| Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase | Q46917092 | ||
| Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. | Q46966126 | ||
| High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-kappaB activation in vascular endothelial cells | Q47235182 | ||
| AMPKalpha1 regulates the antioxidant status of vascular endothelial cells | Q47801068 | ||
| AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress | Q47858200 | ||
| Activation of adenosine-monophosphate-activated protein kinase abolishes desflurane-induced preconditioning against myocardial infarction in vivo | Q48360342 | ||
| 5'-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. | Q50337113 | ||
| Dissecting the role of 5'-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase | Q50337120 | ||
| Activation of rat liver cytosolic 3-hydroxy-3-methylglutaryl coenzyme A reductase kinase by adenosine 5'-monophosphate. | Q53761638 | ||
| Thiazolidinediones: an update. | Q54055332 | ||
| The regulation of AMP-activated protein kinase by phosphorylation | Q55933913 | ||
| The Effect of AMP-Activated Protein Kinase and Its Activator AICAR on the Metabolism of Human Umbilical Vein Endothelial Cells | Q58108374 | ||
| Fluid Shear Stress and NO Decrease the Activity of the Hydroxy-Methylglutaryl Coenzyme A Reductase in Endothelial Cells via the AMP-Activated Protein Kinase and FoxO1 | Q60760123 | ||
| The Nitric Oxide-Donating Pravastatin Derivative, NCX 6550 [(1S-[1 (betaS*, S*), 2 , 6 , 8beta-(R*), 8a ]]-1,2,6,7,8,8a-Hexahydro-beta, , 6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphtalene-heptanoic Acid 4-(Nitrooxy)butyl Ester)], Reduces Sp | Q60998569 | ||
| Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice | Q64018944 | ||
| A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis | Q69907652 | ||
| 5'-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms | Q71824256 | ||
| High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase | Q71892100 | ||
| AMP-activated protein kinase phosphorylation of endothelial NO synthase | Q74456171 | ||
| Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5'-AMP activated protein kinase | Q77410226 | ||
| 5'-AMP-activated protein kinase activation prevents postischemic leukocyte-endothelial cell adhesive interactions | Q80174822 | ||
| Nitric oxide generation by NO donors is enhanced following balloon injury in the porcine coronary artery | Q80320311 | ||
| The effect of PPAR ligands to modulate glucose metabolism alters the incorporation of metabolic precursors into proteoglycans synthesized by human vascular smooth muscle cells | Q81646507 | ||
| Acadesine, an adenosine-regulating agent with the potential for widespread indications | Q94705349 | ||
| The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. | Q34522920 | ||
| Diabetes and atherosclerosis: epidemiology, pathophysiology, and management | Q34646074 | ||
| C-terminal phosphorylation of LKB1 is not required for regulation of AMP-activated protein kinase, BRSK1, BRSK2, or cell cycle arrest | Q34852643 | ||
| Inducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid production | Q35070737 | ||
| Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells | Q35218922 | ||
| A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway | Q35768634 | ||
| Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells | Q35773071 | ||
| NADPH oxidase and endothelial cell function | Q36232155 | ||
| Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. | Q36301403 | ||
| AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer | Q36448932 | ||
| AMP-activated protein kinase: Role in metabolism and therapeutic implications | Q36616554 | ||
| AMP-activated protein kinase in the heart: role during health and disease | Q36749088 | ||
| Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo | Q36761895 | ||
| Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism. | Q36807630 | ||
| Modulation of PPAR activity via phosphorylation | Q36846134 | ||
| Pro-healing drug-eluting stents: a role for antioxidants? | Q37056666 | ||
| In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I | Q37267054 | ||
| AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells | Q37332718 | ||
| Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin | Q37360483 | ||
| Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by reversible phosphorylation and dephosphorylation. | Q37365504 | ||
| Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients | Q37392192 | ||
| AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease | Q37411713 | ||
| Activation and signaling by the AMP-activated protein kinase in endothelial cells | Q37553770 | ||
| The role of AMP-activated protein kinase in the cardiovascular system | Q37632263 | ||
| Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family. | Q38298758 | ||
| A revised model for AMP-activated protein kinase structure: The alpha-subunit binds to both the beta- and gamma-subunits although there is no direct binding between the beta- and gamma-subunits | Q38308990 | ||
| Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome | Q38312576 | ||
| AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway | Q39682741 | ||
| Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation | Q39697365 | ||
| Phenformin has a direct inhibitory effect on the ATP-sensitive potassium channel | Q39734364 | ||
| AMP-activated protein kinase activator A-769662 is an inhibitor of the Na(+)-K(+)-ATPase | Q39787435 | ||
| Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway | Q39788216 | ||
| Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism | Q39815253 | ||
| Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. | Q39878461 | ||
| Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. | Q40178851 | ||
| Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. | Q40223208 | ||
| Phenformin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) activation of AMP-activated protein kinase inhibits transepithelial Na+ transport across H441 lung cells. | Q40416595 | ||
| Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells | Q41901421 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 242-253 | |
| P577 | publication date | 2010-11-25 | |
| P1433 | published in | Pharmacology & Therapeutics | Q3378596 |
| P1476 | title | AMPK and vasculoprotection | |
| P478 | volume | 131 |
| Q37954821 | AMP-activated protein kinase and the control of smooth muscle cell hyperproliferation in vascular disease. |
| Q47912246 | AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-κB/LOX-1 pathway |
| Q37175528 | AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury |
| Q37881988 | AMP-activated protein kinase: a potential player in Alzheimer's disease |
| Q89842749 | AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy |
| Q52430975 | AMPK Phosphorylation of ACE2 in Endothelium Mitigates Pulmonary Hypertension. |
| Q38998402 | AMPK/Mitochondria in Metabolic Diseases |
| Q46142341 | Acetylcholine-induced AMP-activated protein kinase activation attenuates vasoconstriction through an LKB1-dependent mechanism in rat aorta |
| Q51724997 | Activation of AMPK inhibits pulmonary arterial smooth muscle cells proliferation. |
| Q35128571 | Adenosine 5'-monophosphate-activated protein kinase regulates IL-10-mediated anti-inflammatory signaling pathways in macrophages |
| Q92649647 | Adenosine Monophosphate-Activated Protein Kinase Signaling Regulates Lipid Metabolism in Response to Salinity Stress in the Red-Eared Slider Turtle Trachemys scripta elegans |
| Q36288862 | Alterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes |
| Q54229729 | Ampelopsin protects endothelial cells from hyperglycemia-induced oxidative damage by inducing autophagy via the AMPK signaling pathway. |
| Q34444895 | Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease |
| Q39179519 | Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine Danshen |
| Q39379798 | Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention. |
| Q90448263 | Chronic dosing with metformin plus bosentan decreases in vitro pulmonary artery contraction from isolated arteries in adults with pulmonary hypertension |
| Q38733796 | Clinical Trials in Pediatric Autosomal Dominant Polycystic Kidney Disease |
| Q37522889 | Constitutive activation of AMPK α1 in vascular endothelium promotes high-fat diet-induced fatty liver injury: role of COX-2 induction |
| Q95852043 | Contribution of Rho-kinase and Adenosine Monophosphate-Activated Protein Kinase Signaling Pathways to Endothelium-Derived Contracting Factors Responses |
| Q38692469 | Coordinating Regulation of Gene Expression in Cardiovascular Disease: Interactions between Chromatin Modifiers and Transcription Factors |
| Q46826234 | Deletion of AMPKα1 attenuates the anticontractile effect of perivascular adipose tissue (PVAT) and reduces adiponectin release |
| Q33682914 | Dissecting the role of AMP-activated protein kinase in human diseases |
| Q89880144 | GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease-A Systematic Review |
| Q38770370 | Globular CTRP9 inhibits oxLDL-induced inflammatory response in RAW 264.7 macrophages via AMPK activation |
| Q37364108 | Increased ghrelin signaling prolongs survival in mouse models of human aging through activation of sirtuin1. |
| Q40536569 | Inhibition of AMPK through Lyn-Syk-Akt enhances FcεRI signal pathways for allergic response |
| Q34474278 | Loss of NF1 expression in human endothelial cells promotes autonomous proliferation and altered vascular morphogenesis |
| Q37440481 | Metformin-stimulated AMPK-α1 promotes microvascular repair in acute lung injury |
| Q41661696 | Mild caloric restriction reduces blood pressure and activates endothelial AMPK-PI3K-Akt-eNOS pathway in obese Zucker rats. |
| Q42198231 | Nitric oxide synthesis-promoting effects of valsartan in human umbilical vein endothelial cells via the Akt/adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway |
| Q42279758 | Normal IgG downregulates the intracellular superoxide level and attenuates migration and permeability in human aortic endothelial cells isolated from a hypertensive patient |
| Q57283056 | Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword |
| Q37671282 | Perivascular fat, AMP-activated protein kinase and vascular diseases. |
| Q35925959 | Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems |
| Q53065024 | Regulatory effect of AMP-activated protein kinase on pulmonary hypertension induced by chronic hypoxia in rats: in vivo and in vitro studies. |
| Q92814951 | Salidroside attenuates oxidized low‑density lipoprotein‑induced endothelial cell injury via promotion of the AMPK/SIRT1 pathway |
| Q36595077 | Salidroside exerts protective effects against chronic hypoxia-induced pulmonary arterial hypertension via AMPKα1-dependent pathways |
| Q90084151 | TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation |
| Q44405235 | The AMP-Dependent Protein Kinase (AMPK) Activator A-769662 Causes Arterial Relaxation by Reducing Cytosolic Free Calcium Independently of an Increase in AMPK Phosphorylation |
| Q38594411 | The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders |
| Q42137439 | The hypotensive effect of acute and chronic AMP-activated protein kinase activation in normal and hyperlipidemic mice |
| Q49953580 | Toll-like receptor 9-dependent AMPKα activation occurs via TAK1 and contributes to RhoA/ROCK signaling and actin polymerization in vascular smooth muscle cells |
| Q38419222 | Vascular AMPK as an attractive target in the treatment of vascular complications of obesity. |
| Q48211515 | Vitamin D attenuates cerebral artery remodeling through VDR/AMPK/eNOS dimer phosphorylation pathway after subarachnoid hemorrhage in rats. |
Search more.